Hologic (HOLX) PT Raised to $33 at Needham & Company on Strong Q1 Growth Acceleration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Hologic (HOLX) Tops Q1 EPS by 3c; Bumps Outlook
January 28, 2015 4:21 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $652.8 million versus the consensus estimate of $630.79 million.
Hologic sees FY2015 EPS of $1.54-$1.57, versus prior guidance of $1.50-$1.54 and the consensus of $1.54. Hologic... More
